How does Technescan Tc 99m Mertiatide light up my kidneys on a scan?
The tracer is a radioactive isotope (technetium-99m) attached to a kidney-targeting molecule (mertiatide). When injected into your vein, it binds reversibly to blood proteins, then rapidly clears through your kidneys via active tubule secretion and glomerular filtration—both pathways show up as bright spots on the nuclear camera, revealing healthy vs. damaged tissue [1].
The FDA-approved mechanism works because 89% of the tracer sticks to plasma proteins initially, creating a 'carrier' that reaches your kidneys quickly. Once there, the reversible binding releases the tracer, allowing it to be actively pumped out by kidney tubule cells and filtered through the glomerulus—the kidney's blood-cleaning unit. This dual-pathway clearance is why the scan shows both tubular and glomerular function in one image [1].
Your body doesn't metabolize the tracer like a regular drug. Instead, the radioactive technetium-99m decays naturally with a 6-hour half-life, meaning half the radiation dose is gone in 6 hours and 94% is cleared within 24 hours. The mertiatide molecule itself is excreted unchanged in urine, so there's no toxic metabolite buildup—even in patients with severe kidney disease [1].
The scan takes 30 minutes in a nuclear medicine department. A gamma camera detects the radiation emitted by the tracer as it concentrates in your kidneys, creating a real-time movie of how fast the tracer enters, concentrates, and exits each kidney. Your nephrologist compares the uptake and clearance rates to normal values to spot cysts, scarring, obstruction, or reduced filtration rate—findings that blood creatinine alone can miss [1].
Ask your doctor: 'Will this scan change my treatment plan?' If the answer is yes, it's worth the 30 minutes and $93 cost. If your kidney function is already well-managed, ask whether the scan is truly needed or if repeat bloodwork would suffice [1].